The European Commission has outlined the next steps for the universal PFAS restriction. Once ECHA delivers its final scientific assessment by the end of 2026, the Commission will present a restriction proposal aimed at minimising PFAS emissions. The Commission will also consider a ban on PFAS in consumer goods. For industrial applications, continued use may be permitted for critical uses where adequate alternatives are not yet available, but only under strict conditions and time-limited derogations.
The 60-day consultation on SEAC's draft opinion on the PFAS restriction proposal (26 March to 25 May 2026) received 3,511 comments from more than 3,200 organisations and 250 individuals. SEAC is now assessing the contributions and is expected to adopt its final opinion on the proposed restriction by the end of 2026. This represents strong stakeholder engagement in the REACH restriction process.
ECHA’s official Registry of restriction intentions until outcome shows the EU-wide PFAS REACH restriction entry in 'Opinion development' status, with the registry reflecting a latest update date of 16-Apr-2026. This is not an adopted restriction, but it is an authoritative process/status signal that the dossier has progressed into the committee opinion-development phase and is useful for compliance teams monitoring expected timelines and upcoming milestones under the proposed universal PFAS restriction.
ECHA opened a public consultation on the Committee for Socio-Economic Analysis (SEAC) draft opinion in the ongoing REACH restriction process for an EU-wide PFAS restriction proposal. Compliance teams tracking the proposed PFAS restriction should consider participating in the consultation (e.g., providing socio-economic information, use/alternatives data) and monitor subsequent RAC/SEAC opinion finalisation steps that will inform any eventual Commission restriction decision.
ECHA opened a 60-day stakeholder consultation on SEAC’s draft opinion related to the proposed EU-wide REACH restriction on PFAS (universal PFAS proposal). ECHA communications also confirm RAC has adopted its opinion on the restriction proposal and that the committees support an EU-wide restriction with targeted derogations and risk-management measures for derogated uses. Compliance teams should use the open consultation window to submit technical and socioeconomic evidence, especially regarding use essentiality, alternatives, transition timelines, and emission minimisation/management measures that could become conditions of any future restriction.
ECHA posted an official process update indicating support for the proposed EU-wide PFAS restriction under REACH, including discussion of targeted derogations. While not a final legal restriction, this type of update is relevant for compliance teams because it signals likely scope/derogation direction and helps companies anticipate which uses may face bans, conditions, or transition periods in a future Annex XVII restriction.
ECHA posted an official update that its Socio-Economic Analysis Committee (SEAC) agreed its draft opinion on the PFAS restriction proposal under REACH. This signals progression toward final RAC/SEAC opinions and eventual European Commission decision-making for an Annex XVII restriction. Compliance teams should use these committee milestones to accelerate PFAS inventory mapping, use-case justification, and substitution roadmaps aligned to likely restriction parameters and derogations.
ECHA posted an official notice indicating it would launch a consultation on the draft SEAC (Socio-Economic Analysis Committee) opinion for the proposed EU-wide PFAS restriction under REACH. This is a key milestone in the restriction process: companies affected by potential PFAS restrictions should monitor the consultation window and prepare technical and socio-economic input to support derogation requests, transition periods, or alternative-risk-management arguments.
OCR announced a HIPAA enforcement settlement with MMG Fusion, LLC (described as a software company and business associate). OCR cited alleged gaps including failure to conduct an accurate and thorough Security Rule risk analysis and failure to provide timely breach notification to covered entities. The settlement includes a resolution agreement/corrective action plan with multi-year monitoring. For vendor cybersecurity programs, this reinforces that business associates must maintain documented risk analysis, risk management, policies/procedures, and breach notification processes suitable for regulated timelines and contractual commitments.
ECHA published consultation support materials to help stakeholders respond to the consultation on the SEAC draft opinion for the proposed EU-wide REACH restriction on PFAS. The documents provide instructions for respondents and include an annex mapping PFAS uses, which can help companies structure inputs on socio-economic impacts, uses, and potential derogations during the restriction process. This is non-binding guidance (not a legal restriction itself) but is compliance-relevant for companies preparing consultation submissions and assessing potential future PFAS restrictions under REACH.
ECHA announced procedural next steps for the proposed EU-wide REACH restriction on PFAS, stating it plans to launch a 60-day public consultation on SEAC’s draft opinion after the committee meeting in March 2026 (i.e., planned for spring 2026). Compliance teams should anticipate an upcoming consultation window and prepare to submit evidence on uses, socio-economic impacts, and substitution timelines relevant to their PFAS-related products and supply chains.
ECHA’s PFAS hot-topics page highlights an upcoming compliance horizon: restrictions for undecafluorohexanoic acid (PFHxA), its salts and related substances will start applying in April 2026 in the EU/EEA. Compliance teams should use this as a planning trigger to review product portfolios and supply chains for PFHxA-related substances and ensure readiness for EU restriction applicability, including substitution, supplier declarations, and potential reformulation timelines. (The research text does not provide a specific day in April 2026, so no implementation date is recorded.)
ECHA’s PFAS hot-topics page indicates that undecafluorohexanoic acid (PFHxA), its salts and related substances are subject to REACH restrictions starting in April 2026 (referenced as an already adopted restriction with a future start date). Compliance teams supplying or using PFHxA-related substances in the EU/EEA should confirm applicability, assess product/mixture impacts, and plan substitution or supply-chain controls ahead of the April 2026 restriction start date; however, the specific day in April is not provided in the extracted research text.
ECHA’s Registry of SVHC intentions until outcome shows an update (last updated 4 February 2026), reflecting the current status of SVHC identification intentions (e.g., intentions marked withdrawn or progressed). This is SVHC-relevant operational guidance for compliance and regulatory intelligence teams because it provides an official forward-looking view of substances that may be proposed for SVHC identification, supporting proactive supply-chain risk screening and substance substitution planning.
On 4 February 2026, ECHA updated the REACH Candidate List of Substances of Very High Concern (SVHCs) by adding two new entries: (1) n-hexane (EC 203-777-6; CAS 110-54-3), identified under REACH Article 57(f) (human health) due to specific target organ toxicity after repeated exposure; and (2) 4,4′-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and its salts (group entry including bisphenol AF and salts), identified under REACH Article 57(c) (toxic for reproduction). The Candidate List total increased to 253 entries. Compliance teams should assess impacts on downstream REACH SVHC obligations triggered by Candidate List inclusion, including Article 33 communication obligations for SVHCs in articles above 0.1% w/w, Article 7(2) notification duties for SVHCs in articles (within six months of inclusion date as described by ECHA), and ensuring SDS are updated when supplying the substances as such or in mixtures. The official Candidate List table serves as the authoritative record of inclusion and entry details.
ECHA published a notice announcing the next step in the EU-wide PFAS restriction process under REACH: a planned 60-day consultation on SEAC’s draft opinion (socio-economic impacts and alternatives). The consultation is expected to start after SEAC’s March 2026 meeting, run for 60 days, and be conducted via a structured survey (no attachments). This is a key stakeholder engagement milestone for companies and downstream users to prepare socio-economic and alternatives information for the restriction evaluation.
The European Commission confirms that ECHA's assessment of the Universal PFAS restriction proposal is expected to be ready by the end of 2026. The Commission will base its restriction proposal on ECHA's opinion. This timeline provides clarity for compliance planning across affected sectors, with the Commission decision expected in 2027.
ECHA’s Single Programming Document 2026–2028 includes an official planning milestone indicating ECHA aims to finalise the opinion-making process in 2026 for the broad (universal) PFAS restriction proposal under REACH. This is not a legal restriction yet, but it is a credible timeline signal for compliance teams tracking expected EU-wide PFAS controls and potential future substitution/phase-out planning.
ECHA reported progress by the REACH committees (RAC and SEAC) on the proposed EU-wide PFAS restriction, indicating that RAC was expected to adopt its opinion in March 2026 and that SEAC would move toward agreeing a draft opinion for subsequent consultation. For compliance teams, this is a procedural milestone indicating when the proposal may advance to the next stage (consultation and eventual Commission decision), supporting planning for potential future PFAS restrictions across multiple sectors.
ECHA reported progress by its Committee for Risk Assessment (RAC) and Committee for Socio-Economic Analysis (SEAC) in evaluating the proposed EU-wide PFAS restriction under REACH. ECHA indicated RAC is expected to adopt its opinion in March 2026 and SEAC is expected to agree a draft opinion to be followed by a stakeholder consultation. Compliance teams should treat this as a timeline signal for when the restriction proposal could move closer to a Commission decision and begin preparing supply-chain use information and substitution planning for potentially affected PFAS uses.